Editor’s Note
HIER Corporation, a medical device firm specializing in aesthetic dermatology, has received a strategic investment from Amorepacific Holdings to deepen collaboration in the beauty-medical sector.
HIER Corporation, a medical device specialist in aesthetic dermatology, has secured a strategic investment from Amorepacific Holdings and will strengthen collaboration in the beauty-medical field.
HIER Corporation and Amorepacific Holdings announced on July 27 that they have signed an investment agreement to strengthen cooperation in the beauty-medical sector. The investment amount was not disclosed. Through this agreement, the two companies will leverage their respective core competencies to pursue collaboration in developing next-generation beauty-medical solutions that connect professional treatments with everyday skincare.
The companies will collaborate across product planning, research and development, distribution, and marketing by combining HIER Corporation’s aesthetic medical device development capabilities, joint research with medical professionals, and global key opinion leader (KOL) network with Amorepacific’s dermatological science research and skincare technology. As part of this agreement, Amorepacific Holdings has made a strategic investment in HIER Corporation and plans to further strengthen the mid- to long-term partnership.
Based on this agreement, the two companies will pursue development and commercialization of skin beauty-related products including skin boosters, cosmeceuticals, and medical devices; development of post-treatment after-care products and collaboration on hospital and clinic distribution; and joint research and development of raw materials and ingredients as well as marketing activities. They plan to develop integrated solutions connecting professional treatment areas with everyday skincare by combining HIER Corporation’s medical professional network and aesthetic market expertise with Amorepacific’s dermatological research capabilities and brand assets.
HIER Corporation is an aesthetic medical device specialist established in 2021, expanding its business based on medical network-driven research and development and global distribution capabilities. Its flagship product HILO WAVE is a Dual-HA-based collagen booster that combines high-molecular and low-molecular hyaluronic acid, presenting a regeneration-focused skin remodeling approach and expanding its market presence. The company currently operates in Korea, Japan, Indonesia, Vietnam, and several other countries, continuing to expand global partnerships and accumulate clinical evidence.
AIRS Medical Lands Follow-On Investment from Dunamu&Partners, Reaching $6.2M to Fuel Global Expansion
Rosota Raises $965K Seed Round to Build AI-Native Surgical Robots
Bio AI Startup AMPLY Raises Seed Funding From Bluepoint Partners for Everyday Health Diagnostics